참고문헌
- 국립암센터. 국가 암등록 사업 연례 보고서; 2012.
- Fein DA, Lee WR, Amos WR, Hinerman RW, Parsons JT, Mendenhall WM, et al. Oropharyngeal carcinoma treated with radiotherapy: A 30-year experience. Int J Radiat Oncol Biol Phys. 1996;34(2):289-296. https://doi.org/10.1016/0360-3016(95)02028-4
- Masterson L, Tanweer F. The role of sequential chemoradiation for local advanced oropharyngeal carcinoma. Int J Clin Oncol. 2013;18(5):808-816. https://doi.org/10.1007/s10147-012-0448-y
- Preuss SF, Dinh V, Klussmann JP, Semrau R, Mueller RP, Guntinas-Lichius O. Outcome of multimodal treatment for oropharyngeal carcinoma: A single institution experience. Oral Oncol. 2007;43(4):402-407. https://doi.org/10.1016/j.oraloncology.2006.04.015
- Martinez Carrillo M, Tovar Martin I, Martinez Lara I, Ruiz de Almodovar Rivera JM, Del Moral Avila R. Selective use of post-operative neck radiotherapy in oral cavity and oropharynx cancer: A prospective clinical study. Radiat Oncol. 2013;8:103. https://doi.org/10.1186/1748-717X-8-103
- Levendag PC, Teguh DN, Heijmen BJ. Oropharynx. ln: Halperin EC, Perez CA, Brady LW, editors. Principles and practice of radiation oncology. 5th ed. Philadelphia: Lippincott Williams & Wilkins; 2008. p.913-957.
- Psychogios G, Mantsopoulos K, Agaimy A, Koch M, Zenk J, Waldfahrer F, et al. Prognostic factors in limited(T1-2, N0-1) oropharyngeal carcinoma treated with surgery +/- adjuvant therapy. Head Neck. 2013;35(12):1752-1758. https://doi.org/10.1002/hed.23229
- Krstevska V, Stojkovski I, Zafirova-Ivanovska B. Concurrent radiochemotherapy in locally-regionally advanced oropharyngeal squamous cell carcinoma: Analysis of treatment results and prognostic factors. Radiat Oncol. 2012;7:78. https://doi.org/10.1186/1748-717X-7-78
- Agarwal JP, Mallick I, Bhutani R, Ghosh-Laskar S, Gupta T, Budrukkar A, et al. Prognostic factors in oropharyngeal cancer--analysis of 627 cases receiving definitive radiotherapy. Acta Oncol. 2009;48(7):1026-1033. https://doi.org/10.1080/02841860902845839
- Tomita N, Kodaira T, Furutani K, Tachibana H, Hasegawa Y, Terada A, et al. Long-term follow-up and a detailed prognostic analysis of patients with oropharyngeal cancer treated with radiotherapy. J Cancer Res Clin Oncol. 2010;136(4):617-623. https://doi.org/10.1007/s00432-009-0700-7
- Oguejiofor KK, Hall JS, Mani N, Douglas C, Slevin NJ, Homer J, et al. The prognostic significance of the biomarker p16 in oropharyngeal squamous cell carcinoma. Clin Oncol(R Coll Radiol). 2013;25(11):630-638. https://doi.org/10.1016/j.clon.2013.07.003
- Fallai C, Perrone F, Licitra L, Pilotti S, Locati L, Bossi P, et al. Oropharyngeal squamous cell carcinoma treated with radiotherapy or radiochemotherapy: Prognostic role of TP53 and HPV status. Int J Radiat Oncol Biol Phys. 2009;75(4):1053-1059. https://doi.org/10.1016/j.ijrobp.2008.12.088
- Bussu F, Sali M, Gallus R, Petrone G, Zannoni GF, Autorino R, et al. Human papillomavirus(HPV) infection in squamous cell carcinomas arising from the oropharynx: Detection of HPV DNA and p16 immunohistochemistry as diagnostic and prognostic indicators--a pilot study. Int J Radiat Oncol Biol Phys. 2014;89(5):1115-1120. https://doi.org/10.1016/j.ijrobp.2014.04.044
- Masterson L, Moualed D, Liu ZW, Howard JE, Dwivedi RC, Tysome JR, et al. De-escalation treatment protocols for human papillomavirus-associated oropharyngeal squamous cell carcinoma: A systematic review and meta-analysis of current clinical trials. Eur J Cancer. 2014;50(15):2636-2648. https://doi.org/10.1016/j.ejca.2014.07.001
- Lim R, Eaton A, Lee NY, Setton J, Ohri N, Rao S, et al. 18F-FDG PET/CT metabolic tumor volume and total lesion glycolysis predict outcome in oropharyngeal squamous cell carcinoma. J Nucl Med. 2012;53(10):1506-1513. https://doi.org/10.2967/jnumed.111.101402
- Garsa AA, Chang AJ, Dewees T, Spencer CR, Adkins DR, Dehdashti F, et al. Prognostic value of F-FDG PET metabolic parameters in oropharyngeal squamous cell carcinoma. J Radiat Oncol. 2013;2(1):27-34. https://doi.org/10.1007/s13566-012-0065-4
- Lok BH, Setton J, Caria N, Romanyshyn J, Wolden SL, Zelefsky MJ, et al. Intensity-modulated radiation therapy in oropharyngeal carcinoma: Effect of tumor volume on clinical outcomes. Int J Radiat Oncol Biol Phys. 2012;82(5):1851-1857. https://doi.org/10.1016/j.ijrobp.2011.03.029
- Gupta T, Agarwal J, Jain S, Phurailatpam R, Kannan S, Ghosh-Laskar S, et al. Three-dimensional conformal radiotherapy(3D-CRT) versus intensity modulated radiation therapy(IMRT) in squamous cell carcinoma of the head and neck: A randomized controlled trial. Radiother Oncol. 2012;104(3):343-348. https://doi.org/10.1016/j.radonc.2012.07.001
- Lohia S, Rajapurkar M, Nguyen SA, Sharma AK, Gillespie MB, Day TA. A comparison of outcomes using intensity-modulated radiation therapy and 3-dimensional conformal radiation therapy in treatment of oropharyngeal cancer. JAMA Otolaryngol Head Neck Surg. 2014;140(4):331-337. https://doi.org/10.1001/jamaoto.2013.6777
- Lee NY, de Arruda FF, Puri DR, Wolden SL, Narayana A, Mechalakos J, et al. A comparison of intensity-modulated radiation therapy and concomitant boost radiotherapy in the setting of concurrent chemotherapy for locally advanced oropharyngeal carcinoma. Int J Radiat Oncol Biol Phys. 2006;66(4):966-974. https://doi.org/10.1016/j.ijrobp.2006.06.040